ADARx private stock trade

ADARx

Legal NameADARx Pharmaceuticals, Inc.
HeadquartersSan Diego, CA
SectorBioTech

ADARx Pharmaceuticals is a biotechnology company specializing in RNA-editing technologies and drug discovery. The company focuses on developing innovative therapies that target RNA molecules to treat various diseases. ADARx Pharmaceuticals' expertise lies in leveraging RNA-editing techniques to modify and optimize RNA sequences, offering potential solutions for a wide range of medical conditions. The company aims to advance the field of RNA therapeutics by offering user-friendly and customizable drug discovery platforms that have the potential to transform the treatment of diseases by addressing genetic and RNA-related factors.

Learn more about ADARx IPO

Secondary Pricing Information

$ .star in blue circleZX Index Value | Get ZXData access
--ZX Index Value MoM Change
--ZX Index Value VS Reported Marks
pricing graph placeholder
star in blue circleTo view Pre-IPO pricing data for ADARx, log in to ZXData or contact us to request access.
<

Secondary Volume Information

$ .M star in blue circleAggregate Volume | Get ZXData access
volume graph placeholder
star in blue circleTo view Pre-IPO volume data for ADARx, log in to ZXData or contact us to request access.
View More

ZXData is the leading provider of real-time secondary data on private companies. ZXData has the largest dataset of closed trades with $15bn+ in volume. In addition, it incorporates $150bn+ of buy/sell prices and $45bn+ of reported marks to provide private market investors, trading desks, lenders, and companies with unprecedented market intelligence on private companies.